BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 10805354)

  • 21. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
    Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course, prognosis, and cause of death in primary Sjögren's syndrome.
    Horvath IF; Szanto A; Papp G; Zeher M
    J Immunol Res; 2014; 2014():647507. PubMed ID: 24963499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and risk factors of Raynaud's phenomenon in primary Sjögren's syndrome.
    Lin W; Xin Z; Ning X; Li Y; Ren X; Su Y; Liu M; Guo S; Yang L; Liu Y; Zhang F; Zhang W
    Clin Rheumatol; 2021 Oct; 40(10):4081-4087. PubMed ID: 33914202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.
    Brito-Zerón P; Kostov B; Solans R; Fraile G; Suárez-Cuervo C; Casanovas A; Rascón FJ; Qanneta R; Pérez-Alvarez R; Ripoll M; Akasbi M; Pinilla B; Bosch JA; Nava-Mateos J; Díaz-López B; Morera-Morales ML; Gheitasi H; Retamozo S; Ramos-Casals M;
    Ann Rheum Dis; 2016 Feb; 75(2):348-55. PubMed ID: 25433020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren's syndrome: a retrospective cohort study.
    Hui M; Zhao J; Tian Z; Wang J; Qian J; Yang X; Wang Q; Li M; Zhao Y; Zeng X
    Clin Rheumatol; 2019 Feb; 38(2):477-485. PubMed ID: 30218288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality in patients with primary Sjögren's syndrome: a systematic review and meta-analysis.
    Huang H; Xie W; Geng Y; Fan Y; Zhang Z
    Rheumatology (Oxford); 2021 Sep; 60(9):4029-4038. PubMed ID: 33878179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological profiles determine neurological involvement in Sjögren's syndrome.
    Jamilloux Y; Magy L; Hurtevent JF; Gondran G; de Seze J; Launay D; Ly KH; Lambert M; Hachulla E; Hatron PY; Vidal E; Fauchais AL
    Eur J Intern Med; 2014 Feb; 25(2):177-81. PubMed ID: 24176941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
    Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prognosis of patients with primary Sjögren's syndrome].
    Brito-Zerón P; Ramos-Casals M
    Med Clin (Barc); 2008 Feb; 130(3):109-15. PubMed ID: 18261383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary Sjögren's syndrome. A longitudinal study of 68 patients].
    Botsios C; Ostuni P; Sfriso P; Grava C; Andretta M; Todesco S
    Recenti Prog Med; 2001 Dec; 92(12):741-6. PubMed ID: 11822094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    De Vita S; Gandolfo S; Zandonella Callegher S; Zabotti A; Quartuccio L
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):150-156. PubMed ID: 30156548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Sjögren's syndrome and risk of ischemic stroke: a nationwide study.
    Chiang CH; Liu CJ; Chen PJ; Huang CC; Hsu CY; Chan WL; Huang PH; Chen TJ; Lin SJ; Chen JW; Leu HB
    Clin Rheumatol; 2014 Jul; 33(7):931-7. PubMed ID: 24651915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
    Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
    Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.
    Davidson BK; Kelly CA; Griffiths ID
    Rheumatology (Oxford); 1999 Mar; 38(3):245-53. PubMed ID: 10325663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Raynaud's phenomenon in primary Sjögren's syndrome.
    Skopouli FN; Talal A; Galanopoulou V; Tsampoulas CG; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 May; 17(5):618-20. PubMed ID: 2359071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
    Risselada AP; Kruize AA; Bijlsma JW
    Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal involvement in primary Sjögren's syndrome: a clinicopathologic study.
    Maripuri S; Grande JP; Osborn TG; Fervenza FC; Matteson EL; Donadio JV; Hogan MC
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1423-31. PubMed ID: 19679669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
    Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
    Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
    Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
    Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.